Complete

A new way to diagnose and prevent squamous cell carcinoma

Cancer types:

Skin cancer

Project period:

Research institute:

New York University

Award amount:

£194,081

Location:

USA

Researcher Dr Markus Schober

Dr Markus Schober aims to work out how cells rewire their internal programs into a state that helps them turn into cancer cells. 

Meet the scientist

Markus is Assistant Professor in the Department of Biology at New York University in the United States. His expertise in understanding how cancer cells function has led to key discoveries.

The science

Squamous cell carcinoma (SCC) is a group of cancers that originate in cells forming the surface of the skin and lining the internal walls of our organs, respiratory tract and digestive tract. Collectively, these cancers represent the second largest number of cancers worldwide. Many of these cancers are treated successfully in the early stages of the disease, but if diagnosed late, SCC can be much more aggressive and difficult to treat. 

Dr Markus Schober is uncovering the molecular secrets that allow healthy cells to make the switch to becoming SCC cells. Once revealed, this knowledge could lead to new ways to improve the early diagnosis and prevention of SCC. 

Related projects

Complete USA

Skin cancer

How do some skin cancer cells become resistant to treatment?

This project hopes to discover how skin cancer develops resistance to treatments and find ways to overcome it so that survival rates improve.

Researcher: Dr Bin Zheng

Overcoming drug resistance in skin cancer

Active United Kingdom

Bowel cancer

Journey to the centre of a cell: why does age matter in cancer?

With your support, Professor Lesley Stark and her team in Edinburgh hope to find new ways to prevent cancer linked to ageing.

Researcher: Professor Lesley Stark

Journey to the centre of a cell: why does age matter in cancer?

Active Spain

General cancer research

Can ‘2 in 1’ therapy improve how we treat cancer?

Our project in Spain is exploring an innovative new 'dual-action' cancer cure

Researcher: Dr Edurne Rujas

Can ‘2 in 1’ therapy improve how we treat cancer?
Share this page